Urinary tract infections

Primary Care - Clinics in Office Practice

Volumn 40, Issue 3, 2013, Pages 687-706

  Wang, Alina ^a   Nizran, Parminder ^a   Malone, Michael A ^a   Riley, Timothy ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Complicated UTI; Pyelonephritis; Urinary tract infection; UTI

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFACLOR; CEFALEXIN; CEFDINIR; CEFEPIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITRITE; NITROFURANTOIN; PHENAZOPYRIDINE; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIURIA; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; DIAGNOSTIC TEST; DIPSTICK TESTING; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; ECHOGRAPHY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MEDICAL HISTORY; MICROSCOPY; NONHUMAN; OUTPATIENT CARE; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; PYELONEPHRITIS; PYURIA; RECURRENT INFECTION; REVIEW; RISK FACTOR; SEXUAL INTERCOURSE; SINGLE DRUG DOSE; STAPHYLOCOCCUS SAPROPHYTICUS; UNSPECIFIED SIDE EFFECT; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

COMPLICATED UTI; PYELONEPHRITIS; URINARY TRACT INFECTION; UTI;

AGE FACTORS; ANESTHETICS, LOCAL; ANTI-INFECTIVE AGENTS, URINARY; DRUG RESISTANCE, MICROBIAL; HUMANS; PHENAZOPYRIDINE; PRIMARY HEALTH CARE; PYELONEPHRITIS; RISK FACTORS; SEX FACTORS; SEXUAL BEHAVIOR; UNITED STATES; URINALYSIS; URINARY TRACT INFECTIONS;

EID: 84882246782     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2013.06.005     Document Type: Review

References (114)

1. Pace W.D., Dickinson L.M., Staton E.W. Seasonal variation in diagnoses and visits to family physicians. Ann Fam Med 2004, 2(5):411-417.
2. Fihn S.D. Clinical practice. Acute uncomplicated urinary tract infection in women. NEngl J Med 2003, 349(3):259-266.
3. Krieger J.N., Ross S.O., Simonsen J.M. Urinary tract infections in healthy university men. JUrol 1993, 149(5):1046.
4. Vorland L.H., Carlson K., Aalen O. An epidemiological survey of urinary tract infections among outpatients in Northern Norway. Scand J Infect Dis 1985, 17(3):277.
5. Czaja C.A., Scholes D., Hooton T.M., et al. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007, 45(3):273.
6. Jackson S.L., Boyko E.J., Scholes D., et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004, 117(12):903.
7. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52(5):e103.
8. Hameed A., Chinegwundoh F., Thwaini A. Prevention of catheter-related urinary tract infections. Br J Hosp Med (Lond) 2010, 71(3):148-150. 151-2.
9. Klevens R.M., Edwards J.R., Richards C.L., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122(2):160-166.
10. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005, 142(1):20.
11. Hooton T.M., Scholes D., Hughes J.P., et al. Aprospective study of risk factors for symptomatic urinary tract infection in young women. NEngl J Med 1996, 335(7):468-474.
12. Fihn S.D., Boyko E.J., Chen C.L., et al. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Intern Med 1998, 158(3):281-287.
13. Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997, 11(3):551.
14. Tiemstra J.D., Chico P.D., Pela E. Genitourinary infections after a routine pelvic exam. JAm Board Fam Med 2011, 24(3):296-303.
15. Bent S., Nallamothu B.K., Simel D.L., et al. Does this woman have an acute uncomplicated urinary tract infection?. JAMA 2002, 287(20):2701-2710.
16. Hwang J.H., Park H.C., Jeong J.C., et al. Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol 2013, 14:1.
17. Echols R.M., Tosiello R.L., Haverstock D.C., et al. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis 1999, 29(1):113.
18. Grabe M, Bjerklund-Johansen TE, Botto H, etal, European Association of Urology (EAU). Guidelines on urological infections. EAU 2013.
19. Nicolle L.E. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005, 16(6):349-360.
20. Warren J.W. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1987, 1(4):823-854.
21. Hooton T.M. Clinical practice. Uncomplicated urinary tract infection. NEngl J Med 2012, 366(11):1028-1037.
22. Gupta K., Trautner B. In the clinic. Urinary tract infection. Ann Intern Med 2012, 156(5). ITC3-1-15.
23. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. JAntimicrob Chemother 2003, 51(1):69.
24. Naber K.G., Schito G., Botto H., et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008, 54(5):1164.
25. Zhanel G.G., Hisanaga T.L., Laing N.M., et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006, 27(6):468.
26. Sanchez G.V., Master R.N., Karlowsky J.A., et al. Invitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents Chemother 2012, 56(4):2181-2183.
27. Swami S.K., Liesinger J.T., Shah N., et al. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc 2012, 87(8):753-759.
28. Prakash V., Lewis J.S., Herrera M.L., et al. Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrobial Agents Chemother 2009, 53(3):1278-1280.
29. Miller L.G., Tang A.W. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004, 79(8):1048.
30. Schito G.C., Naber K.G., Botto H., et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009, 34(5):407.
31. Ho P.L., Yip K.S., Chow K.H., et al. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn Microbiol Infect Dis 2010, 66(1):87.
32. Bhat R.G., Katy T.A., Place F.C. Pediatric urinary tract infections. Emerg Med Clin North Am 2011, 29(3):637-653.
33. Stamm W.E. Measurement of pyuria and its relation to bacteriuria. Am J Med 1983, 75(1B):53.
34. Wilson M.L., Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004, 38(8):1150.
35. Little P., Turner S., Rumsby K., et al. Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specificity of near patient tests (dipsticks) and clinical scores. Br J Gen Pract 2006, 56(529):606-612.
36. Pappas P.G. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am 1991, 75(2):313.
37. Little P., Turner S., Rumsby K., et al. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess 2009, 13(19):iii-iv. ix-xi, 1-73.
38. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29(4):745.
39. McIsaac W.J., Low D.E., Biringer A., et al. The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med 2002, 162(5):600.
40. Mehnert-Kay S.A. Diagnosis and management of uncomplicated urinary tract infections. Am Fam Physician 2005, 72(3):451-456.
41. Gupta K., Hooton T.M., Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001, 135(1):41.
42. Meyrier A., Condamin M.C., Fernet M., et al. Frequency of development of early cortical scarring in acute primary pyelonephritis. Kidney Int 1989, 35(2):696.
43. Tsugaya M., Hirao N., Sakagami H., et al. Computerized tomography in acute pyelonephritis: the clinical correlations. JUrol 1990, 144(3):611.
44. Kawashima A., LeRoy A.J. Radiologic evaluation of patients with renal infections. Infect Dis Clin North Am 2003, 17(2):433.
45. Johnson J.R., Vincent L.M., Wang K., et al. Renal ultrasonographic correlates of acute pyelonephritis. Clin Infect Dis 1992, 14(1):15.
46. Demertzis J., Menias C.O. State of the art: imaging of renal infections. Emerg Radiol 2007, 14(1):13.
47. Sandberg T., Stokland E., Brolin I., et al. Selective use of excretory urography in women with acute pyelonephritis. JUrol 1989, 141(6):1290.
48. Kanel K.T., Kroboth F.J., Schwentker F.N., et al. The intravenous pyelogram in acute pyelonephritis. Arch Intern Med 1988, 148(10):2144.
49. Nicolle L.E., Mayhew W.J., Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987, 83(1):27-33.
50. Ouslander J.G., Shapira M., Schnelle J.F., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?. Ann Intern Med 1995, 122:749-754.
51. Boscia J.A., Kobasa W.D., Knight R.A., et al. Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA 1987, 257:1062-1071.
52. Mohler J.L., Cowen D.L., Flanigan R.C. Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. JUrol 1987, 138:336-340.
53. Warren J.W., Anthony W.C., Hoopes J.M., et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982, 248:454-458.
54. Harding G.K., Nicolle L.E., Ronald A.R., et al. How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 1991, 114:713-719.
55. Harding G.K., Zhanel G.G., Nicolle L.E., Manitoba Diabetic Urinary Infection Study Group, et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. NEngl J Med 2002, 347:1576-1583.
56. Klimberg I., Shockey G., Ellison H., et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin 2005, 21(8):1241-1250.
57. Falagas M.E., Kotsantis I.K., Vouloumanou E.K., et al. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. JInfect 2009, 58(2):91-102.
58. Christiaens T.C., De Meyere M., Verschraegen G., et al. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002, 52(482):729-734.
59. McKinnell J.A., Stollenwerk N.S., Jung C.W., et al. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc 2011, 86(6):480.
60. Gupta K., Hooton T.M., Roberts P.L., et al. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007, 167(20):2207.
61. Iravani A., Klimberg I., Briefer C., et al. Atrial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. JAntimicrob Chemother 1999, 43(Suppl A):67.
62. Stein G.E. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999, 21(11):1864.
63. Kavatha D., Giamarellou H., Alexiou Z., et al. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrobial Agents Chemother 2003, 47(3):897.
64. Arredondo-García J.L., Figueroa-Damián R., Rosas A., et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. JAntimicrob Chemother 2004, 54(4):840.
65. Sanchez G.V., Master R.N., Bordon J. Trimethoprim-sulfamethoxazole may no longer be acceptable for the treatment of acute uncomplicated cystitis in the United States. Clin Infect Dis 2011, 53(3):316-317.
66. Metlay J.P., Strom B.L., Asch D.A. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003, 51(4):963.
67. Wagenlehner F.M., Schmiemann G., Hoyme U., et al. National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients. Urologe A 2011, 50(2):153-169. [in German].
68. Van Pienbroek E., Hermans J., Kaptein A.A., et al. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci 1993, 15(6):257-262.
69. Graninger W. Pivmecillinam-therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 2003, 22(Suppl 2):73.
70. Nicolle L.E., Madsen K.S., Debeeck G.O., et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002, 34(7):487.
71. Richard G.A., Mathew C.P., Kirstein J.M., et al. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002, 59(3):334.
72. Fourcroy J.L., Berner B., Chiang Y.K., et al. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrobial Agents Chemother 2005, 49(10):4137.
73. Hooton T.M., Besser R., Foxman B., et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004, 39(1):75.
74. Hooton T.M., Scholes D., Gupta K., et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005, 293(8):949.
75. Rodríguez-Baño J., Alcalá J.C., Cisneros J.M., et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008, 168(17):1897.
76. Ulleryd P., Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis 2003, 35:34-39.
77. Jimenez-Cruz F., Josovich A., Cajigas J., et al. Aprospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology 2002, 60:16-22.
78. Cox C.E., Marbury T.C., Pittman W.G., et al. Arandomized, double-blind multicenter comparison of gatifloxacin vs ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Clin Ther 2002, 24:223-236.
79. Tomera K.M., Burdmann E.A., Pamo Reyna O.G., et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized double-blind multicenter study. Antimicrobial Agents Chemother 2002, 46:2895-2900.
80. Naber K.G., Savov O., Salmen H.C. Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents 2002, 19:95-103.
81. Raz R., Naber N.G., Raizenberg C., et al. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women. Eur J Clin Microbiol Infect Dis 2000, 19:327-331.
82. Krcmery S., Naber N.G. Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. Int J Antimicrob Agents 1999, 11:133-138.
83. Klimberg I.W., Cox C.E., Fowler C.L., et al. Acontrolled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology 1998, 51:610-615.
84. Frankenschmidt A., Naber K.G., Bischoff W., et al. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections. JUrol 1997, 158:1494-1499.
85. Pisani E., Bartoletti R., Trinchieri A., et al. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. J Chemother 1996, 8:210-213.
86. Naber K.G., di Silverio F., Geddes A., et al. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. JAntimicrob Chemother 1996, 37(Suppl A):135-144.
87. Dow G., Rao P., Harding G., et al. Aprospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 2004, 39(5):658-664.
88. Nicolle L.E. Catheter-related urinary tract infection. Drugs Aging 2005, 22(8):627.
89. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. NEngl J Med 1993, 329(18):1328.
90. Nicolle L.E. Apractical guide to the management of complicated urinary tract infection. Drugs 1997, 53(4):583.
91. Pitout J.D. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70(3):313.
92. Mombelli G., Pezzoli R., Pinoja-Lutz G., et al. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999, 159(1):53.
93. Ward G., Jorden R.C., Severance H.W. Treatment of pyelonephritis in an observation unit. Ann Emerg Med 1991, 20(3):258.
94. Sanchez M., Collvinent B., Miró O., et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg Med J 2002, 19(1):19.
95. Epp A., Larochelle A., Lovatsis D., et al. Recurrent urinary tract infection. JObstet Gynaecol Can 2010, 32(11):1082-1090.
96. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990, 80(3):331.
97. Foxman B., Gillespie B., Koopman J., et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000, 151(12):1194.
98. Ikäheimo R., Siitonen A., Heiskanen T., et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996, 22(1):91.
99. Shields J., Maxwell A.P. Acute pyelonephritis can have serious complications. Practitioner 2010, 254(1728):19. 21, 23-4, 2.
100. Brumbaugh A.R., Mobley H.L. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 2012, 11(6):663-676.
101. White B. Diagnosis and treatment of urinary tract infection in children. Am Fam Physician 2011, 83(4):409-415.
102. Stenqvist K., Sandberg T., Lidin-Janson G., et al. Virulence factors of Escherichia coli in urinary isolates from pregnant women. JInfect Dis 1987, 156(6):870-877.
103. Naeye R.L. Causes of the excessive rates of perinatal mortality and prematurity in pregnancies complicated by maternal urinary-tract infections. NEngl J Med 1979, 300:819.
104. Millar L.K., Cox S.M. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997, 11:13.
105. Patterson T.F., Andriole V.T. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am 1997, 11:593.
106. Delzell J.E., Lefevre M.L. Urinary tract infections during pregnancy. Am Fam Physician 2000, 61:713.
107. Kass E.H. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960, 105:194.
108. Smaill F., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007, (2). CD000490.
109. Lang J.M., Lieberman E., Cohen A. Acomparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology 1996, 7:369.
110. Millar L.K., DeBuque L., Wing D.A. Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth. JPerinat Med 2003, 31:41.
111. Whalley P.J., Martin F.G., Peters P.C. Significance of asymptomatic bacteriuria detected during pregnancy. JAMA 1965, 193:879.
112. Rouse D.J., Andrews W.W., Goldenberg R.L., et al. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstet Gynecol 1995, 86:119.
113. Mittendorf R., Williams M.A., Kass E.H. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis 1992, 14:927.
114. Zinner S.H., Kass E.H. Long-term (10 to 14 years) follow-up of bacteriuria of pregnancy. NEngl J Med 1971, 285:820.